Advertisement
Screener

IVERIC bio, Inc. Costs and Expenses

IVERIC bio, Inc. Costs and Expenses

IVERIC bio, Inc. reported Costs and Expenses of $44.02 million for the 3-month period ending 2015-06-30, per its 10-Q filed 2015-08-10.

Discontinued › Expense Statement › Operating Expenses

us-gaap:CostsAndExpenses · last filed 2015-08-10

  • IVERIC bio, Inc. costs and expenses for the quarter ending 2015-06-30 was $44.02M, a 4.12% increase year-over-year.
  • IVERIC bio, Inc. costs and expenses for the quarter ending 2015-03-31 was $34.14M, a 64.73% increase year-over-year.
  • IVERIC bio, Inc. costs and expenses for the quarter ending 2014-12-31 was $32.85M, a 60.69% increase year-over-year.
  • IVERIC bio, Inc. costs and expenses for the quarter ending 2014-09-30 was $25.92M, a 69.76% increase year-over-year.
  • IVERIC bio, Inc. costs and expenses for fiscal 2014 was $121.77M, a 156.77% increase from fiscal 2013.
  • IVERIC bio, Inc. costs and expenses for fiscal 2013 was $47.42M, a 246.65% increase from fiscal 2012.
  • IVERIC bio, Inc. costs and expenses for fiscal 2012 was $13.68M, a 30.32% decline from fiscal 2011.
  • IVERIC bio, Inc. costs and expenses for fiscal 2011 was $19.63M.
Period endCosts and Expenses 3 monthCosts and Expenses 6 monthCosts and Expenses 9 monthCosts and Expenses 12 monthCosts and Expenses 81 monthCosts and Expenses 84 monthCosts and Expenses 87 month
2015-06-30$44.02M
10-Q · filed 2015-08-10
$78.16M
10-Q · filed 2015-08-10
$111.01M
derived: sum of 3 quarters · filed 2015-08-10
$136.93M
derived: sum of 4 quarters · filed 2015-08-10
2015-03-31$34.14M
10-Q/A · filed 2015-07-28
$66.99M
derived: sum of 2 quarters · filed 2015-07-28
$92.91M
derived: sum of 3 quarters · filed 2015-07-28
$135.19M
derived: sum of 4 quarters · filed 2015-08-10
2014-12-31$32.85M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2015-07-28
$58.77M
derived: sum of 2 quarters · filed 2015-07-28
$101.05M
derived: sum of 3 quarters · filed 2015-08-10
$121.77M
10-K/A · filed 2015-07-28
2014-09-30$25.92M
10-Q · filed 2014-11-12
$68.19M
derived: sum of 2 quarters · filed 2015-08-10
$88.92M
10-Q · filed 2014-11-12
$109.36M
derived: sum of 4 quarters · filed 2015-08-10
2014-06-30$42.28M
10-Q · filed 2015-08-10
$63.00M
10-Q · filed 2015-08-10
$83.45M
derived: sum of 3 quarters · filed 2015-08-10
$98.71M
derived: sum of 4 quarters · filed 2015-08-10
2014-03-31$20.73M
10-Q/A · filed 2015-07-28
$41.17M
derived: sum of 2 quarters · filed 2015-07-28
$56.44M
derived: sum of 3 quarters · filed 2015-07-28
$64.02M
derived: sum of 4 quarters · filed 2015-07-28
$170.39M
10-Q · filed 2014-05-13
2013-12-31$20.44M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2015-07-28
$35.71M
derived: sum of 2 quarters · filed 2015-07-28
$43.30M
derived: sum of 3 quarters · filed 2015-07-28
$47.42M
10-K/A · filed 2015-07-28
$149.67M
10-K · filed 2014-03-11
2013-09-30$15.27M
10-Q · filed 2014-11-12
$22.85M
derived: sum of 2 quarters · filed 2014-11-12
$26.98M
10-Q · filed 2014-11-12
$30.53M
derived: sum of 4 quarters · filed 2015-07-28
$129.22M
10-Q · filed 2013-11-13
2013-06-30$7.59M
10-Q · filed 2014-08-06
$11.71M
10-Q · filed 2014-08-06
$15.26M
derived: sum of 3 quarters · filed 2015-07-28
$19.11M
derived: sum of 4 quarters · filed 2015-07-28
2013-03-31$4.13M
10-Q · filed 2014-05-13
$7.67M
derived: sum of 2 quarters · filed 2015-07-28
$11.53M
derived: sum of 3 quarters · filed 2015-07-28
2012-12-31$3.55M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2015-07-28
$7.40M
derived: sum of 2 quarters · filed 2015-07-28
$13.68M
10-K/A · filed 2015-07-28
2012-09-30$3.85M
10-Q · filed 2013-11-13
$10.13M
10-Q · filed 2013-11-13
2011-12-31$19.63M
10-K · filed 2014-03-11